Scarica l'app Stockscreener
3.50
8.62%
-0.33
Pre-mercato:
3.48
-0.02
-0.57%
Precedente Chiudi:
$3.83
Aprire:
$3.65
Volume 24 ore:
282.77K
Relative Volume:
0.07
Capitalizzazione di mercato:
$11.19M
Reddito:
$7.15M
Utile/perdita netta:
$4.03M
Rapporto P/E:
-0.6481
EPS:
-5.4
Flusso di cassa netto:
$-11.33M
1 W Prestazione:
-24.57%
1M Prestazione:
+169.23%
6M Prestazione:
-53.89%
1 anno Prestazione:
-53.89%
Intervallo 1D:
$3.44
$3.7713
Intervallo di 1 settimana:
$3.44
$6.29
Portata 52W:
$0.8225
$12.31
Trxade Health Inc Stock (MEDS) Company Profile
Nome
Trxade Health Inc
Settore
Industria
Telefono
(800) 261 0281
Indirizzo
2420 BRUNELLO TRACE, LUTZ, FL
Compare MEDS vs HITI, PETS, SCNX, POM
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MEDS
Trxade Health Inc
|
3.50 | 11.19M | 7.15M | 4.03M | -11.33M | -5.40 |
HITI
High Tide Inc
|
2.695 | 240.24M | 486.49M | -33.29M | 10.86M | -0.3627 |
PETS
Petmed Express Inc
|
1.555 | 33.71M | 179.02M | -57.29M | -33.01M | -2.7487 |
SCNX
Scienture Holdings Inc
|
0.287 | 11.79M | 656.60K | -16.79M | -11.12M | -1.0743 |
POM
Pomdoctor Ltd Adr
|
0.97 | 8.99M | 0 | 0 | 0 | 0.00 |
Trxade Health Inc Borsa (MEDS) Ultime notizie
DataMEDS AI, Inc. (NASDAQ: MEDS) Share Price, MEDS Stock News, MEDS Share Price & Updates - kalkine.com.au
Scienture Holdings Reports Q2 2026 Results, Launches REZENOPY™ and Narrows Losses - Quiver Quantitative
Wellgistics Health Inc. (MEDS) Live Share Price, Invest From India - INDmoney
WELLGISTICS HEALTH, INC. OFFICIALLY CHANGES CORPORATE NAME TO DATAMEDS AI, INC. - Stock Titan
SCNX - Finviz
Trxade Health announces name change to Scienture Holdings - Intellectia AI
MEDS Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million - Intellectia AI
TRxADE Health, Inc. Announces Name Change to Scienture Holdings, Inc. - Intellectia AI
MEDS Stock: Price, Forecast, Financials & AI Analysis - Intellectia AI
MEDS News & Events - Intellectia AI
Wellgistics Health Taps Former Optum, Evernorth Executives in Major Leadership Overhaul for Digital Transformation - Stock Titan
SCIENTURE Appoint Dr. Shankar Hariharan and Dr. Narasimhan Mani as Co-CEO’s - citybiz
Integra Pharma Solutions, LLC (d/b/a TRxADE Prime(TM) (a TRxADE HEALTH Company) Secures Preferred Distribution Agreement with GALT Pharmaceuticals, LLC - ACCESS Newswire
TRxADE Group, Inc. Announces Name Change to TRxADE HEALTH, INC. - ACCESS Newswire
Datameds AI (MEDS) Stock Price, News & Analysis - Stock Titan
Bonum Health(TM), LLC (a TRxADE HEALTH Company) Reaffirms its Commitment to Independent Pharmacies and Group Purchasing Organizations (GPOs) with its Novel Telemedicine Services Model - ACCESS Newswire
Oragenics Appoints Janet Huffman As Interim CEO - citybiz
Urgent Company Parent Co. Sued By Eat Well Investment Group - Nosh.com
Group Alleges $10M 'Sham' In Fla. Plant-Based Co. Stock Deal - Law360
UK Compounding Pharmacies Market Size & Outlook, 2023-2030 - Grand View Research
DataMeds AI Inc (NASDAQ: MEDS)Share Price - intelligentinvestor.com.au
TRxADE Health changes its name to Scienture Holdings - AlphaStreet
MEDS Price History for Trxade Health Stock - Barchart.com
Trxade Health (MEDS) Q2 2024 Research Summary - AlphaStreet
TRxADE HEALTH, INC 10-Q Report - TradingView
About Us - FinancialContent
Dykema Guides TRxADE in Another Acquisition - Dykema
Tampa pharma company stacked with former McKesson execs launches IPO - The Business Journals
MEDS Earnings: Highlights of Trxade Health’s Q1 2024 financial results - AlphaStreet
TRxADE HEALTH (MEDS) Stock News & Updates - Stock Titan
TRxADE HEALTH, INC. Releases Q1 2024 10-Q Report Highlighting Strategic Shifts and Financial Performance - TradingView
Trxade Group Confronts Compliance Issues and Board Changes - TipRanks
Trxade Health Inc. (NASDAQ: MEDS) Q1 2024 Research Summary - AlphaStreet
TRxADE HEALTH, INC. Releases 10-K Report Highlighting Financial and Strategic Developments - TradingView
TRxADE Health, Inc. Announces Special Cash Dividend - Stock Titan
Trxade Health Surges 40% On Special Dividend - RTTNews
Why Is Trxade Health (MEDS) Stock Up 230% Today? - InvestorPlace
Dykema Completes Sale of Assets for TRxADE Health, Inc. - Dykema
Trxade Health Inc. (NASDAQ: MEDS) Q4 2023 Research Summary - AlphaStreet
MEDS Earnings: A snapshot of Trxade Health’s Q3 2023 financial results - AlphaStreet
TRxADE: Q3 Earnings Snapshot - qz.com
TRxADE HEALTH, INC. Releases Q3 10-Q Report Highlighting Strategic Shifts and Financial Performance - TradingView
Superlatus, Newly Merged with TRxADE HEALTH, Acquires the assets of Spero Foods, a plant-based tech company Disrupting the Dairy and Egg Industry. - Yahoo Finance
Food technology company prepares to enter plant-based pet nutrition market - Pet Food Processing
The Week in AgriFoodTech: Toyota does indoor farming, Bayer & Pairwise ink deal, cultivated seafood gets big in Japan - AgFunderNews
Superlatus into snacks with protein twists - Food Business News
Perfect Day Agrees To Sell D2C Arm The Urgent Company for $1.25M - Green Queen Media
Trxade Health (MEDS) Stock Is Moving Higher: What's Going On? - Benzinga
Twilio (TWLO) Earnings: 2Q23 Key Numbers - AlphaStreet
Artemis Strategic (ARTE) to Combine with Danam Health in $200M Deal - SPACInsider
Trxade Health Inc Azioni (MEDS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.93%
21.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):